Levemir Injection, Solution
Product Images NDC 0169-6432

Product Visual Gallery

This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Levemir (NDC 0169-6432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\smart\labeling\products\levemir\figures\chemical Structure.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 01)

FDA Label Image

Figure 4a (Aa947266 E27c 432b 8e04 C36168d24ddb 06)

FDA Label Image

Figure 4b (Aa947266 E27c 432b 8e04 C36168d24ddb 07)

FDA Label Image

Figure 6 (Aa947266 E27c 432b 8e04 C36168d24ddb 08)

FDA Label Image

Figure 7 (Aa947266 E27c 432b 8e04 C36168d24ddb 09)

FDA Label Image

Figure 8 (Aa947266 E27c 432b 8e04 C36168d24ddb 10)

FDA Label Image

Figure 9 (Aa947266 E27c 432b 8e04 C36168d24ddb 11)

FDA Label Image

Figure 10 (Aa947266 E27c 432b 8e04 C36168d24ddb 12)

FDA Label Image

Figure 1 (Aa947266 E27c 432b 8e04 C36168d24ddb 13)

FDA Label Image

Step 1 Fig B.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 28)

FDA Label Image

Step 2 Fig C.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 29)

FDA Label Image

Figure D (Aa947266 E27c 432b 8e04 C36168d24ddb 30)

FDA Label Image

Figure E (Aa947266 E27c 432b 8e04 C36168d24ddb 31)

FDA Label Image

Figure F (Aa947266 E27c 432b 8e04 C36168d24ddb 32)

FDA Label Image

Figure G (Aa947266 E27c 432b 8e04 C36168d24ddb 33)

FDA Label Image

Step 7 Fig H.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 34)

FDA Label Image

Step 8 Fig I.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 35)

FDA Label Image

Step 9 Fig J.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 36)

FDA Label Image

Step 10 Fig K.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 37)

FDA Label Image

Step 10 Fig L (Aa947266 E27c 432b 8e04 C36168d24ddb 38)

FDA Label Image

Step 11 Fig M (Aa947266 E27c 432b 8e04 C36168d24ddb 39)

FDA Label Image

Step 12 Fig N.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 40)

FDA Label Image

Step 13 Fig O.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 41)

FDA Label Image

Step 13 Fig P.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 42)

FDA Label Image

Step 14 Fig Q.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 43)

FDA Label Image

Step 15 Fig S.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 45)

FDA Label Image

Step 16 Fig T.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 46)

FDA Label Image

Flextouch Qr Code (Aa947266 E27c 432b 8e04 C36168d24ddb 50)

FDA Label Image

Image Of Levemir Vial Carton (Image 01)

FDA Label Image

Flextouch (Image 02)

FDA Label Image

Needle Components. (Image 03)

FDA Label Image

Figure A Flextouch Pen Components. (Image 04)

FDA Label Image

Step 15 Figure R (Image 05)

FDA Label Image

Figure 2: Activity Profiles In Patients With Type 1 Diabetes (Image 06)

The text seems to be a graph showing pharmacodynamic parameters for Levemir, with glucose infusion rate and time since insulin injection on the x-axis and y-axis respectively. The graph is divided into two lines, one for 0.2 Units/kg dose and the other for 0.4 Units/kg dose. The graph also shows the area under the curve for glucose infusion rate and the maximum glucose infusion rate.*

FDA Label Image

Figure 3: Activity Profiles In Patients With Type 2 Diabetes (Image 07)

This is a chart showing pharmacodynamic parameters for Levemir, a drug used to treat diabetes. The chart displays the Glucose Infusion Rate (mg/kg/min) over time since insulin injection (hours) for two different doses of Levemir (0.6 Units/kg and 1.2 Units/kg). The graph also includes two pharmacodynamic parameters: AUCa or Area Under Curve Glucose Infusion Rate and GIRmax or Maximum Glucose Infusion Rate.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.